Form 4: RxSight Executive Sells Shares
Insider Transaction (Form 4)
Ronald M Kurtz, Chief Medical Officer of RxSight, Inc., sold 5,100 shares of common stock on August 31, 2026 for $6.96 per share.
Summary
- Option exercise/conversion: acquired 13,425 Common Stock on August 31, 2026; holds 76,875 after (Direct).
- Open-market sale: disposed of 5,100 Common Stock at $6.96 ($35,496) on September 2, 2026; holds 71,775 after (Direct).
- Option exercise/conversion: disposed of 13,425 Restricted Stock Unit on August 31, 2026; holds 67,120 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $35,496 of stock on the open market.
Insider Transactions
Ronald M Kurtz — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Option exercise/conversion | Common Stock | 13,425 | — | — | 76,875 |
| 2026-09-02 | Open-market sale | Common Stock | 5,100 | $7 | $35.5K | 71,775 |
| 2026-08-31 | Option exercise/conversion | Restricted Stock Unit | 13,425 | — | — | 67,120 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Option exercise/conversion (13,425 shares) |
| 2026-09-02 | Open-market sale (5,100 shares) |
| 2026-08-31 | Option exercise/conversion (13,425 shares) |
Keywords
insider transaction, Form 4, RXST, RxSight, Inc., bearish, Ronald M Kurtz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.